معرفی
James Evans is a Research Fellow at the Francis Crick Institute and UCL Queen Square Institute of Neurology. His research employs induced pluripotent stem cell (iPSC) models, advanced imaging, and transcriptomics to investigate glial involvement in Parkinson's disease pathogenesis. Evans maintains an active research profile with no indications of part-time status or retirement.
Research Focus: Evans specializes in deciphering molecular mechanisms underlying Parkinson's disease, particularly emphasizing mitochondrial dysfunction, protein aggregation (notably alpha-synuclein), neuroinflammation, and glial contributions to neurodegeneration. His work integrates stem cell biology, genomics, and cutting-edge microscopy techniques to develop diagnostic models and therapeutic strategies.
Publication Trends: Evans' 15 most recent articles (2022–2025) predominantly explore Parkinson's disease mechanisms through cellular and molecular lenses. Key themes include mitochondrial pathology, glial activation, genetic determinants (e.g., GBA1, SNCA), and innovative therapeutic approaches like GLP1 receptor agonism and antisense oligonucleotides. His research consistently bridges basic science with translational applications.
